Preliminary Effects of Mobile Computerized Cognitive Training in Adults with Mild Cognitive Impairment: Interim Analysis of a Randomized Controlled Trial

Overview

Journal BMC Psychol

Publisher Biomed Central

Specialty Psychology

Date 2025 Mar 5

PMID 40045413

Authors

Drin Ferizaj

Oskar Stamm

Luis Perotti

Eva Maria Martin

Kathrin Finke

Carsten Finke

Tilo Strobach

Anika Heimann-Steinert

Affiliations

Soon will be listed here.

Abstract

Computerized cognitive training (cCT) is a non-invasive treatment strategy in which individuals repeatedly practice computer-based tasks targeting specific cognitive functions. While traditional face-to-face cognitive training is costly and accompanied by long waiting times, mobile cCT can improve the healthcare situation due to its accessibility and versatility. This interim analysis of the NeuroNation MED Effectiveness Study (NeNaE) explores the initial effects of a mobile, gamified cCT (NeuroNation MED) on cognitive and psychosocial outcomes in adults diagnosed with mild cognitive impairment (MCI; ICD-10 code F06.7). In the intention-to-treat analysis, the intervention group (IG) performed 12 weeks of training with the NeuroNation MED app, while the control group (CG) served as a waiting group. This interim analysis included the first 50 participants (IG: n = 36; CG: n = 14). The primary outcome was the index score of the Neuropsychological Assessment Battery Screening Module (S-NAB). Alpha spending resulted in an alpha level of 0.00305 for this interim analysis. This analysis provided preliminary evidence suggesting potential benefits of the intervention, with the IG demonstrating a significant improvement in the S-NAB index score (t(35) = 3.17, p = 0.0028, Cohen's d = 0.53). However, ANCOVA revealed no significant group differences between IG and CG in the S-NAB index score (F(1, 47) = 5.39, p = 0.025, η = 0.125). Additionally, the IG showed a significant mean decrease in subjective cognitive failures measured by the CFQ-D (MD = -10.56, SD = 18.82, t(35) = 3.21, p = 0.0029, Cohen's d = 0.53). ANCOVA showed no significant group difference in CFQ-D post-test scores when controlling for pre-test scores (F(1, 47) = 4.81, p = 0.033, η = 0.095). Analyzing the full study data is crucial to determine the effectiveness of the NeuroNation MED application for MCI.Trial registrationDRKS00025133, Date of registration: November 5, 2021.

References

Wan F . Statistical analysis of two arm randomized pre-post designs with one post-treatment measurement. BMC Med Res Methodol. 2021; 21(1):150. PMC: 8305561. DOI: 10.1186/s12874-021-01323-9. View

Downie S, Shnaigat M, Hosseinzadeh H . Effectiveness of health literacy- and patient activation-targeted interventions on chronic disease self-management outcomes in outpatient settings: a systematic review. Aust J Prim Health. 2022; 28(2):83-96. DOI: 10.1071/PY21176. View

Ferizaj D, Stamm O, Perotti L, Martin E, Ophey A, Rekers S . Effectiveness of a mobile application for independent computerized cognitive training in patients with mild cognitive impairment: study protocol for the NeNaE Study, a randomized controlled trial. Trials. 2024; 25(1):444. PMC: 11223296. DOI: 10.1186/s13063-024-08277-5. View

Stites S, Harkins K, Rubright J, Karlawish J . Relationships Between Cognitive Complaints and Quality of Life in Older Adults With Mild Cognitive Impairment, Mild Alzheimer Disease Dementia, and Normal Cognition. Alzheimer Dis Assoc Disord. 2018; 32(4):276-283. PMC: 6249095. DOI: 10.1097/WAD.0000000000000262. View

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

Clifton L, Clifton D . The correlation between baseline score and post-intervention score, and its implications for statistical analysis. Trials. 2019; 20(1):43. PMC: 6330413. DOI: 10.1186/s13063-018-3108-3. View

Gates N, Vernooij R, Di Nisio M, Karim S, March E, Martinez G . Computerised cognitive training for preventing dementia in people with mild cognitive impairment. Cochrane Database Syst Rev. 2019; 3:CD012279. PMC: 6415132. DOI: 10.1002/14651858.CD012279.pub2. View

Fritz C, Morris P, Richler J . Effect size estimates: current use, calculations, and interpretation. J Exp Psychol Gen. 2011; 141(1):2-18. DOI: 10.1037/a0024338. View

Bahar-Fuchs A, Webb S, Bartsch L, Clare L, Rebok G, Cherbuin N . Tailored and Adaptive Computerized Cognitive Training in Older Adults at Risk for Dementia: A Randomized Controlled Trial. J Alzheimers Dis. 2017; 60(3):889-911. DOI: 10.3233/JAD-170404. View

10.

Martin E, Srowig A, Utech I, Schrenk S, Kattlun F, Radscheidt M . Persistent cognitive slowing in post-COVID patients: longitudinal study over 6 months. J Neurol. 2023; 271(1):46-58. PMC: 10769987. DOI: 10.1007/s00415-023-12069-3. View

11.

Klumb P . Cognitive failures and performance differences: validation studies of a German version of the cognitive failures questionnaire. Ergonomics. 1995; 38(7):1456-67. DOI: 10.1080/00140139508925202. View

12.

Lovett R, Curtis L, Persell S, Griffith J, Cobia D, Federman A . Cognitive impairment no dementia and associations with health literacy, self-management skills, and functional health status. Patient Educ Couns. 2020; 103(9):1805-1811. PMC: 7864102. DOI: 10.1016/j.pec.2020.03.013. View

13.

Vos S, van Rossum I, Verhey F, Knol D, Soininen H, Wahlund L . Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI. Neurology. 2013; 80(12):1124-32. DOI: 10.1212/WNL.0b013e318288690c. View

14.

Bohlken J, Weber K, Riedel Heller S, Michalowsky B, Kostev K . Mild Cognitive Disorder in Post-COVID-19 Syndrome: A Retrospective Cohort Study of 67,000 Primary Care Post-COVID Patients. J Alzheimers Dis Rep. 2022; 6(1):297-305. PMC: 9277697. DOI: 10.3233/ADR-220020. View

15.

Djabelkhir L, Wu Y, Vidal J, Cristancho-Lacroix V, Marlats F, Lenoir H . Computerized cognitive stimulation and engagement programs in older adults with mild cognitive impairment: comparing feasibility, acceptability, and cognitive and psychosocial effects. Clin Interv Aging. 2017; 12:1967-1975. PMC: 5702161. DOI: 10.2147/CIA.S145769. View

16.

Stokin G, Krell-Roesch J, Petersen R, Geda Y . Mild Neurocognitive Disorder: An Old Wine in a New Bottle. Harv Rev Psychiatry. 2015; 23(5):368-76. PMC: 4894762. DOI: 10.1097/HRP.0000000000000084. View

17.

Lampit A, Hallock H, Valenzuela M . Computerized cognitive training in cognitively healthy older adults: a systematic review and meta-analysis of effect modifiers. PLoS Med. 2014; 11(11):e1001756. PMC: 4236015. DOI: 10.1371/journal.pmed.1001756. View

18.

Kumar A, Chakraborty B . Interim analysis: A rational approach of decision making in clinical trial. J Adv Pharm Technol Res. 2016; 7(4):118-122. PMC: 5052936. DOI: 10.4103/2231-4040.191414. View

19.

Cong L, Ren Y, Wang Y, Hou T, Dong Y, Han X . Mild cognitive impairment among rural-dwelling older adults in China: A community-based study. Alzheimers Dement. 2022; 19(1):56-66. PMC: 10078715. DOI: 10.1002/alz.12629. View

20.

Savulich G, Piercy T, Fox C, Suckling J, Rowe J, OBrien J . Cognitive Training Using a Novel Memory Game on an iPad in Patients with Amnestic Mild Cognitive Impairment (aMCI). Int J Neuropsychopharmacol. 2017; 20(8):624-633. PMC: 5569993. DOI: 10.1093/ijnp/pyx040. View